Sponsored by:
To build or buy? Examining the pros of building vs. buying a biorepository facility
Biopharma companies face a critical decision: should they invest in building an in-house biorepository or partner with an external provider for their storage and management needs? Each approach has its benefits, from full control and customization to cost savings and scalability.
Our in-depth white paper, "To Build or Buy: Examining the Pros of Building vs. Buying a Biorepository Facility," explores:
- The cost, time, and resource implications of building a facility.
- The advantages of outsourcing, including risk mitigation and global scalability.
- Key factors to consider when making this strategic decision.
Make an informed choice that aligns with your research goals, budget, and operational needs.
